AHA: Tirzepatide Beneficial for Heart Failure With Preserved EF, Obesity

FRIDAY, Nov. 22, 2024-- For patients with heart failure with preserved ejection fraction, tirzepatide yields a reduced risk for a composite of death from cardiovascular causes or worsening heart failure, according to a study published online Nov...